Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01149109 |
Recruitment Status :
Completed
First Posted : June 23, 2010
Last Update Posted : June 14, 2017
|
Sponsor:
University Hospital, Bonn
Information provided by (Responsible Party):
Ulrich Herrlinger, University Hospital, Bonn
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 6, 2017 |
Actual Study Completion Date : | April 6, 2017 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):